- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Davis Today
By the People, for the People
Advances in Cat Allergy Research Offer Hope for Allergy Sufferers
From Fel d 1-blocking antibodies to personalized allergy profiles, the future of cat ownership for those with allergies is looking brighter.
Published on Feb. 3, 2026
Got story updates? Submit your updates here. ›
Recent breakthroughs in cat allergy research are challenging the conventional wisdom and offering new hope for allergy sufferers seeking feline companionship. Researchers are working on a Fel d 1-blocking antibody that could significantly reduce allergen production, while genetic research is paving the way for breeders to selectively breed cats with naturally lower levels of the protein. Additionally, the development of personalized 'pet allergy profiles' is helping prospective owners identify cats they are less likely to react to, even within breeds not traditionally considered hypoallergenic.
Why it matters
The quest for a truly hypoallergenic cat has driven breeders and pet parents alike for decades. These advancements in allergy research and management could open up the joys of cat ownership to a wider audience, allowing more people to experience the benefits of feline companionship without the debilitating effects of allergies.
The details
Researchers at the University of California, Davis, are actively working on a Fel d 1-blocking antibody, essentially a 'vaccine' for cats that could significantly reduce allergen production. Early trials, reported in 2023, showed promising results, with a substantial decrease in Fel d 1 levels on cats' coats. Alongside the antibody approach, genetic research is gaining momentum, with scientists identifying the genes responsible for Fel d 1 production and paving the way for breeders to selectively breed cats with naturally lower levels of the protein. Additionally, the development of 'pet allergy profiles' can help prospective owners identify cats they are less likely to react to, even within breeds not traditionally considered hypoallergenic.
- In 2023, early trials of the Fel d 1-blocking antibody showed promising results.
- In the coming years, expect to see more breeders advertising 'low-allergen' lines within popular breeds like Maine Coons and Ragdolls.
The players
University of California, Davis
A research institution where scientists are actively working on a Fel d 1-blocking antibody, a potential 'vaccine' for cats that could significantly reduce allergen production.
AllergiEnd
A company that offers 'pet allergy profiles' - comprehensive tests that analyze an individual's specific allergic responses to different cat allergens, including variations of Fel d 1.
What’s next
While not yet commercially available, the Fel d 1-blocking antibody represents a potential paradigm shift in making any cat more allergy-friendly, not just specific breeds.
The takeaway
These advancements in allergy research and management, from Fel d 1-blocking antibodies to personalized allergy profiles, are opening up the joys of cat ownership to a wider audience, allowing more people to experience the benefits of feline companionship without the debilitating effects of allergies.
